Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Amgen Ventures

VC INVESTOR TYPE
Active STATUS
2 PROFESSIONALS
78 INVESTMENTS
23 PORTFOLIO
34 EXITS
Description

Amgen Ventures is the corporate venture arm of Amgen. The firm prefers to invest in the biotechnology firms focused on oncology, inflammation, digital health and health tech sectors. The firm was established in 2004 and is based in Thousand Oaks, California.

Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
2004
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • One Amgen Center Drive
  • Thousand Oaks, CA 91320
  • United States

+1 (805) 000-0000

Amgen Ventures Investments (78)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Nkarta Therapeutics 04-Sep-2019 Early Stage VC 00000 Biotechnology Generating Revenue
00000 000000000000 25-Apr-2019 0000 00000 000 Biotechnology Product In Beta Test 000000 00000
000 0000000000 11-Apr-2019 00000 00000 000.00 Decision/Risk Analysis Generating Revenue
00000 00000000000 21-Mar-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 2
000000 04-Feb-2019 00000 00000 000.00 Database Software Generating Revenue 00000 00000 00.0
00000000 000000000 26-Nov-2018 00000 00000 0000 Drug Discovery Startup
0000000 19-Nov-2018 0000 00000 00.00 Drug Discovery Generating Revenue 000000 00000
0000000000 13-Nov-2018 00000 00000 0000 Biotechnology Generating Revenue
Opsona Therapeutics 26-Aug-2018 Later Stage VC 00.000 Drug Discovery Bankruptcy: Liquidation
Akili Interactive 08-Aug-2018 Later Stage VC 0000 Other Healthcare Technology Systems Clinical Trials - General
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Amgen Ventures’s full profile, request a free trial.

Amgen Ventures Exits (34)

Company Name Exit Date Exit Type Exit Size Status Buyers
Precision BioSciences 28-Mar-2019 IPO 00000 Completed
0000000 07-Feb-2019 000 00000 Completed
000000 00000000000 13-Jan-2019 0000000000: 000000 Completed
00000 000000000 27-Sep-2018 000 0000 Completed
0000000000 0000000 09-Jul-2018 000000000000000000 Completed
  • 00000000
0000000 00000000 19-Apr-2018 000 00000 Completed
  • 00000000 000000000
0000000 0000000 29-Nov-2017 0000000000: 000000 Completed
00000 000000000000 05-Apr-2017 000000000 00000000 Completed
NexImmune 14-Feb-2017 Merger/Acquisition Completed
Ziarco 20-Jan-2017 Merger/Acquisition 000 Completed
To view this investor’s complete exits history, request access »

Amgen Ventures Team (8)

Name Title Deals Funds Boards Office Contact
Info
Janis Naeve Ph.D Managing Director 00 0 0 South San Francisco, CA
Gladys Nunez Principal 0 0 0 Cambridge, MA
Rachna Khosla Vice President, Business Development Thousand Oaks, CA

5 Former Team Members

You’re viewing 3 of 8 team members. Get the full list »